SPIOLTO® RESPIMAT®
Overview
Product overview
SPIOLTO® RESPIMAT® is indicated as a maintenance bronchodilator treatment in adult patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Product Key Facts
![product_key2](/tw/sites/default/files/2023-02/product_key2_0.png)
Indications
Chronic obstructive pulmonary disease (COPD).
![product_key3](/tw/sites/default/files/2023-02/product_key3_0.png)
Active ingredient
Tiotropium/olodaterol.
![product_key4](/tw/sites/default/files/2023-02/product_key4_0.png)
Legal category
Prescription only medicine.
![product_key5](/tw/sites/default/files/2023-02/product_key5_0.png)
Concentration
Tiotropium 2.5 micrograms/olodaterol 2.5 micrograms per puff.
![product_Key7](/tw/sites/default/files/2023-02/product_Key7_0.png)
Administration form
Oral inhalation via RESPIMAT® inhaler.
![product_key6](/tw/sites/default/files/2023-02/product_key6_0.png)
Dosage form
Inhalation solution.
![product_key1](/tw/sites/default/files/2023-02/product_key1_0.png)
Pack sizes
Single pack: One RESPIMAT®
reusable inhaler and one 4-mL
cartridge.
Reference:
-
SPIOLTO® RESPIMAT® Solution for Inhalation, approved package insert. R1g/UK/SPC/a 16/06/2015. Approved 10/2020.